title: Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
authors.affiliation: Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1497, New York, NY 10029, USA.
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Scott
authors.forename: Steven A
authors.initials: SA
authors.lastname: Lubitz
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D019934:International Normalized Ratio / Q000379:methods; D010597:Pharmacogenetics / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D014859:Warfarin
keywords: CYP2C9; VKORC1; clinical utility; pharmacogenetics; pharmacogenomics; randomized controlled clinical trial; warfarin